Over $6 a share !!! Congratulations!

[Anonymous]

simply, JNJ is looking at you.

Your stent share is getting killed by MDT and ICD's will be flat for years(40% of BSX revenue?). Yout pipleline has one future good product in TAVI but its a five player market in 2015.

When Abbott and Biotroniks bioabsorbales hit the market, you guys are TOAST, Say goodbye to billions in revenue

 

[Anonymous]

simply, JNJ is looking at you.

Your stent share is getting killed by MDT and ICD's will be flat for years(40% of BSX revenue?). Yout pipleline has one future good product in TAVI but its a five player market in 2015.

When Abbott and Biotroniks bioabsorbales hit the market, you guys are TOAST, Say goodbye to billions in revenue

The only hope for survival for BSX is if they buy BIO and STJ recalls their Durata lead. They cannot compete head-to-head with anyone.